Re:Time to curtail the excesses of vested interest
[Edited by Sharon Davies on 25 August 2011 on legal advice]
I refer to a BMJ Group press release published on the Wall Street
Journal website last week 'BMJ Group Chooses SDL to Support Medical
Translations for Univadis Online Platform'. Anyone reading either the
title or indeed the entire text of the release might suppose that
'Univadis' was a BMJ product rather than the information arm of
pharmaceutical manufacturer MSD (Merck Sharp & Dohme).
When Dr Godlee was challenged about this in March she explained that
this and other conflicts on the part of BMJ editorial staff had not been disclosed in an editorial and two ‘editors’ choices' that accompanied Mr Brian
Deer's allegations against Andrew Wakefield over MMR because "it did not
occur to us to do so" . Well, surely it must have done now.
 'BMJ Group Chooses SDL to Support Medical Translations for
Univadis Online Platform'
 Fiona Godlee 'In response to John Stone'
Competing interests: Autistic son